Myelodysplastic syndromes (MDS) are clonal disorders of the hematopoietic stem cell characterized by ineffective hematopoiesis leading to peripheral cytopenias. Different processes are involved in ...

Myelodysplastic syndromes (MDS) is a group of blood cancers. Red and white blood cells and platelets start as immature blood stem cells. In MDS, your blood stem cells do not mature into full ...

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory ...

Neutropenia: a condition in which the body has a low ... therapy — which is already approved in the U.S. — for adults with lower-risk myelodysplastic syndromes who have anemia requiring frequent red ...

Geron could have a tougher time than it anticipated at tomorrow’s FDA advisory committee meeting for myelodysplastic syndromes (MDS ... points to a high risk of neutropenia and thrombocytopenia ...